For stabilized patients undergoing complex PCI, left ventricular unloading with an Impella CP microaxial flow pump ...
A massive international study could upend 40 years of heart attack treatment. Researchers found that beta blockers—routinely prescribed after uncomplicated heart attacks—offered no real benefit for ...
Coronary microvascular dysfunction (CMD) was an important independent component of ischemic heart disease, though it often ...
Positive CardiAMP CMI Trial open-label cohort results demonstrated opportunity for locally delivered cell therapy to enhance therapeutic ...
Myocardial infarction remains one of the leading causes of death worldwide. Following an infarction, part of the heart muscle ...
BACKGROUND: The optimal transfusion strategy in patients with acute myocardial infarction (AMI) and anemia may be influenced by sex differences in pathophysiology and cardiovascular outcomes. The ...
Research for other indications is ongoing. In the first trial of microRNA inhibition to treat heart failure, a novel agent did not reduce left ventricular end-systolic volume index at 6 months ...
CardiAMP autologous cell therapy in chronic myocardial ischemic with refractory angina (BCDA-02) Primary results of this cohort have been accepted for oral presentation at Euro PCR, a world-leading ...
Takotsubo syndrome (TTS) is an acute and reversible form of heart failure characterised by transient left ventricular (LV) dysfunction in the absence of obstructive coronary artery disease and often ...
Sickle cell disease (SCD) is the most common genetic haemoglobinopathy worldwide. Due to advancements in care, SCD patients are living longer. Consequently, there is increased interest in long term ...
Cardiac physiologic pacing, also known as cardiac resynchronization therapy, is indicated in patients with heart failure, reduced left ventricular ejection fraction (LVEF) of 50% or less, and either a ...
Please provide your email address to receive an email when new articles are posted on . An AI model accurately detected features of myocardial ischemia and coronary microvascular and vasomotor ...